Cataract Clinical Trial
Official title:
Evaluation of Surgical Outcomes of Cataract Surgery
The purpose of this study is to evaluate the visual outcome of the cataract surgery, including best uncorrected and corrected visual acuity, spherical equivalent, wavefront aberration and other measurements.
Status | Recruiting |
Enrollment | 20000 |
Est. completion date | December 2030 |
Est. primary completion date | December 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 90 Years |
Eligibility | Inclusion Criteria: - Clinical diagnosis of cataract - Must be able to cooperate with the ophthalmic examination Exclusion Criteria: - Clinical diagnosis of mental illness - Mentally disabled |
Country | Name | City | State |
---|---|---|---|
China | Eye and ENT Hospital of Fudan University | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Evidence Based Cataract Study Group |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | The difference between attempted and achieved refractive correction at one month after cataract surgery | Follow-up until one month after surgery | ||
Other | The difference between attempted and achieved refractive correction at six months after cataract surgery | Follow-up until six months after surgery | ||
Primary | Change from baseline in visual acuity at one month after cataract surgery | Follow-up until one month after surgery | ||
Primary | Change from baseline in spherical equivalent at one month after cataract surgery | Follow-up until one month after surgery | ||
Primary | Change from baseline in visual acuity at six months after cataract surgery | Follow-up until six months after surgery | ||
Primary | Change from baseline in spherical equivalent at six months after cataract surgery | Follow-up until six months after cataract surgery | ||
Secondary | Change from baseline in wavefront aberration at one month after cataract surgery | Follow-up until one month after surgery | ||
Secondary | Change from baseline in contrast sensitivity at one month after cataract surgery | Follow-up until one month after surgery | ||
Secondary | Change from baseline in intraocular light scattering at one month after cataract surgery | Follow-up until one month after surgery | ||
Secondary | Change from baseline in wavefront aberration at six months after cataract surgery | Follow-up until six months after surgery | ||
Secondary | Change from baseline in contrast sensitivity at six months after cataract surgery | Follow-up until six months after surgery | ||
Secondary | Change from baseline in intraocular light scattering at six months after cataract surgery | Follow-up until six months after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |